Anxiety
Conditions
Interventions
Oxytocin group:Participants received either an intranasal dose of oxytocin (24 IU, distributed across three sprays per nostril with each spray delivering 4 IU, manufactured by Sichuan Meike Pharmaceut
Placebo group :The placebo group participants received nasal spray of placebo solution (0.9% sodium chloride), with the same frequency and method of nasal spray as the intervention group. And the cond
Sponsors
Institution for Brain and Psychological Science, Sichuan Normal University
Eligibility
Sex/Gender
Male
Age
18 Years to 25 Years
Inclusion criteria
Inclusion criteria: 1. Male aged 18-25 years old; 2. No mental or neurological disorders, no medication taken for at least 15 days before and on the day of the experiment. 3. Right handedness; 4. I have signed an informed consent form and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1. Drug or alcohol abuse 2. Other mental disorders, such as those caused by drug use, bipolar disorder, organic brain disorders, personality disorders, etc. 3. Having rhinitis or common cold 4. I have been taking medication or receiving treatment (such as electromagnetic therapy) in the past three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| US expectancy rating;Valence rating;Arousal rating;Fear intensity rating; | — |
Countries
China
Contacts
Public ContactYi Lei
Sichuan Normal University
Outcome results
None listed